Nifty
Sensex
:
:
24008.00
79454.47
-265.80 (-1.09%)
-880.34 (-1.10%)

Pharmaceuticals & Drugs - Domestic

Rating :
N/A

BSE: 531349 | NSE: PANACEABIO

429.05
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  420.00
  •  430.15
  •  402.15
  •  391.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  727095
  •  3080.14
  •  581.90
  •  112.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,004.96
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,886.10
  • N/A
  • 3.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.48%
  • 2.09%
  • 18.45%
  • FII
  • DII
  • Others
  • 1.16%
  • 0.00%
  • 5.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.04
  • 0.55
  • -5.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -14.46
  • 7.10
  • 8.73

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -35.95
  • -64.04
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 0.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -1.04
  • 4.49
  • 1.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -235.86
  • -377.06
  • -654.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
163.49
150.50
8.63%
147.35
143.02
3.03%
115.72
129.19
-10.43%
136.46
128.93
5.84%
Expenses
155.53
150.65
3.24%
140.35
146.58
-4.25%
129.71
139.50
-7.02%
142.50
134.60
5.87%
EBITDA
7.96
-0.15
-
7.00
-3.56
-
-13.99
-10.31
-
-6.04
-5.67
-
EBIDTM
4.87%
-0.10%
4.75%
-2.49%
-12.09%
-7.98%
-4.43%
-4.40%
Other Income
3.62
5.68
-36.27%
4.65
3.23
43.96%
3.80
6.08
-37.50%
10.81
15.06
-28.22%
Interest
0.99
0.85
16.47%
0.98
0.91
7.69%
0.87
1.00
-13.00%
0.82
1.05
-21.90%
Depreciation
8.98
9.11
-1.43%
8.68
9.31
-6.77%
8.73
9.48
-7.91%
8.81
9.51
-7.36%
PBT
4.38
-1.65
-
4.76
-7.78
-
-17.05
13.03
-
-2.12
18.21
-
Tax
-0.06
0.55
-
0.05
0.51
-90.20%
-1.17
2.05
-
-0.13
30.89
-
PAT
4.44
-2.20
-
4.71
-8.29
-
-15.88
10.98
-
-1.99
-12.68
-
PATM
2.72%
-1.46%
3.20%
-5.80%
-13.72%
8.50%
-1.46%
-9.83%
EPS
0.74
-0.37
-
0.78
-1.37
-
-2.58
1.78
-
-0.23
-2.02
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
563.02
559.17
459.95
661.23
624.80
544.06
456.70
592.79
544.01
653.08
687.19
Net Sales Growth
2.06%
21.57%
-30.44%
5.83%
14.84%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
 
Cost Of Goods Sold
197.21
230.12
252.66
262.20
204.63
156.79
172.24
187.25
149.52
215.81
280.21
Gross Profit
365.81
329.04
207.29
399.03
420.17
387.27
284.45
405.55
394.50
437.27
406.98
GP Margin
64.97%
58.84%
45.07%
60.35%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
Total Expenditure
568.09
579.23
557.90
674.43
548.18
518.57
589.83
508.26
496.89
541.37
643.31
Power & Fuel Cost
-
35.95
31.95
37.82
30.94
29.74
34.55
33.52
30.55
25.15
30.73
% Of Sales
-
6.43%
6.95%
5.72%
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
Employee Cost
-
149.57
126.48
182.97
156.17
144.42
147.08
151.59
148.12
142.02
135.98
% Of Sales
-
26.75%
27.50%
27.67%
25.00%
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
Manufacturing Exp.
-
68.25
47.24
78.70
43.22
33.38
44.31
40.05
41.88
39.47
43.97
% Of Sales
-
12.21%
10.27%
11.90%
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
General & Admin Exp.
-
53.43
43.77
53.79
47.48
54.20
71.07
40.39
52.98
39.41
56.82
% Of Sales
-
9.56%
9.52%
8.13%
7.60%
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
Selling & Distn. Exp.
-
28.52
42.70
48.08
51.18
42.81
31.27
36.98
37.70
44.20
44.20
% Of Sales
-
5.10%
9.28%
7.27%
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
Miscellaneous Exp.
-
13.39
13.10
10.86
14.56
57.24
89.31
18.48
36.14
35.31
44.20
% Of Sales
-
2.39%
2.85%
1.64%
2.33%
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
EBITDA
-5.07
-20.06
-97.95
-13.20
76.62
25.49
-133.13
84.53
47.12
111.71
43.88
EBITDA Margin
-0.90%
-3.59%
-21.30%
-2.00%
12.26%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
Other Income
22.88
25.80
51.66
10.97
9.98
30.35
5.06
8.23
46.59
20.35
28.48
Interest
3.66
3.58
4.44
180.84
185.34
173.98
104.83
100.58
100.93
127.33
104.53
Depreciation
35.20
36.71
39.12
43.78
45.59
44.13
55.03
58.53
67.95
73.32
67.24
PBT
-10.03
-34.56
-89.86
-226.85
-144.32
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
Tax
-1.31
2.98
46.55
371.02
1.96
16.95
8.56
9.86
-10.98
1.92
3.08
Tax Rate
13.06%
202.72%
363.67%
25.60%
-1.36%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
PAT
-8.72
-1.17
-33.23
1,078.31
-146.24
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
PAT before Minority Interest
-7.91
-1.50
-33.74
1,078.33
-146.20
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
Minority Interest
0.81
0.33
0.51
-0.02
-0.04
0.03
0.06
2.02
1.72
2.34
1.79
PAT Margin
-1.55%
-0.21%
-7.22%
163.08%
-23.41%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-1.42
-0.19
-5.42
175.91
-23.86
-31.75
6.13
-12.10
-8.93
-3.02
-16.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
842.05
843.60
876.64
-228.69
198.79
350.40
308.68
355.68
448.61
471.29
Share Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
6.13
22.43
22.43
Total Reserves
835.92
837.48
870.51
-234.82
160.66
344.27
302.55
349.55
426.18
448.76
Non-Current Liabilities
265.09
270.70
85.10
959.99
740.66
70.08
591.13
718.78
1,100.11
918.47
Secured Loans
0.00
0.18
0.24
675.05
583.55
8.90
560.45
704.57
866.08
721.77
Unsecured Loans
20.99
19.98
33.87
60.03
29.58
37.22
10.26
9.49
1.00
1.20
Long Term Provisions
199.27
198.02
29.16
30.65
42.74
39.78
26.54
18.36
184.42
180.43
Current Liabilities
308.83
329.73
773.77
449.09
622.14
938.26
695.52
689.13
474.80
706.03
Trade Payables
153.68
177.32
234.72
246.66
198.85
269.71
277.19
248.60
187.87
209.13
Other Current Liabilities
119.33
115.71
503.01
189.06
242.12
585.25
242.00
237.52
93.60
194.85
Short Term Borrowings
0.00
0.00
0.00
0.00
3.57
69.39
164.88
190.71
191.82
295.84
Short Term Provisions
35.82
36.70
36.03
13.37
177.60
13.92
11.44
12.30
1.51
6.21
Total Liabilities
1,412.15
1,440.54
1,732.53
1,177.39
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
Net Block
569.26
599.95
622.07
608.70
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
Gross Block
1,311.87
1,330.83
1,313.94
1,266.39
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
Accumulated Depreciation
742.62
730.88
691.87
657.69
624.84
587.34
656.87
598.70
549.18
489.18
Non Current Assets
926.97
874.32
744.57
666.41
875.27
847.84
1,027.55
1,070.91
1,475.22
1,573.49
Capital Work in Progress
101.50
42.32
17.26
34.42
24.01
22.51
39.92
30.41
115.78
110.31
Non Current Investment
0.07
0.07
0.07
0.07
5.58
5.33
5.25
7.01
5.19
10.20
Long Term Loans & Adv.
242.44
228.23
21.46
17.62
187.70
13.33
28.01
22.03
236.71
262.44
Other Non Current Assets
1.11
3.74
83.71
5.61
0.60
1.12
5.39
10.09
1.26
1.07
Current Assets
485.18
562.32
950.55
510.97
683.27
507.89
564.83
703.22
549.38
525.72
Current Investments
40.36
13.42
5.00
0.00
0.00
0.00
2.03
0.27
3.52
4.98
Inventories
177.94
202.09
212.72
174.14
147.69
81.43
334.21
315.55
305.24
310.22
Sundry Debtors
57.42
60.09
81.66
84.68
68.52
88.73
136.01
142.17
141.67
98.57
Cash & Bank
139.48
225.99
583.28
135.79
89.75
23.48
23.24
14.13
22.93
52.40
Other Current Assets
69.97
8.41
8.75
52.64
377.31
314.25
69.36
231.09
76.02
59.55
Short Term Loans & Adv.
58.00
52.31
59.15
63.72
41.62
41.02
59.30
56.21
66.76
50.15
Net Current Assets
176.34
232.59
176.79
61.88
61.13
-430.38
-130.69
14.08
74.58
-180.31
Total Assets
1,412.15
1,436.64
1,695.12
1,177.38
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
-0.10
-422.45
-108.45
106.76
-30.47
104.80
118.02
130.67
90.69
37.23
PBT
1.48
12.81
1,449.36
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
Adjustment
-8.76
-95.87
-1,454.97
230.88
253.04
-70.58
166.62
149.57
148.75
167.45
Changes in Working Capital
9.69
-336.91
300.86
21.91
-97.50
127.32
21.45
43.32
-58.26
-25.16
Cash after chg. in Working capital
2.41
-419.98
295.25
107.76
-21.80
102.97
121.93
125.71
71.56
42.88
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.51
-2.48
-403.70
-1.00
-8.67
1.83
-3.91
4.96
19.13
-5.65
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
10.23
430.33
1,282.57
-47.68
-34.76
-5.27
55.29
-25.83
16.44
-37.38
Net Fixed Assets
-43.47
-13.92
-26.71
28.01
223.59
488.74
-15.06
-27.48
11.93
-29.48
Net Investments
0.00
0.00
0.00
54.26
-51.99
342.34
0.00
49.78
0.00
-0.46
Others
53.70
444.25
1,309.28
-129.95
-206.36
-836.35
70.35
-48.13
4.51
-7.44
Cash from Financing Activity
-2.81
-18.37
-1,175.84
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
Net Cash Inflow / Outflow
7.32
-10.49
-1.72
11.97
25.51
-1.61
8.97
-2.13
-10.25
-0.85
Opening Cash & Equivalents
39.85
50.35
52.08
40.22
14.47
16.44
7.47
9.59
19.97
20.84
Closing Cash & Equivalent
47.17
39.85
50.35
52.08
40.22
14.47
16.44
7.47
9.73
19.99

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
137.48
137.73
143.12
-37.34
27.23
57.21
50.40
58.07
-4.43
-0.75
ROA
-0.11%
-2.12%
74.05%
-10.69%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
ROE
-0.18%
-3.92%
332.85%
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
ROCE
0.59%
1.94%
217.12%
5.36%
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
Fixed Asset Turnover
0.43
0.36
0.54
0.51
0.41
0.30
0.37
0.35
0.40
0.41
Receivable days
37.70
54.62
43.66
42.68
52.75
89.81
85.16
92.84
67.10
51.36
Inventory Days
121.93
159.84
101.55
89.66
76.86
166.09
198.91
203.06
171.89
140.68
Payable days
262.50
297.63
335.05
397.33
178.20
213.56
186.55
163.89
130.73
137.37
Cash Conversion Cycle
-102.87
-83.17
-189.84
-264.98
-48.60
42.34
97.52
132.00
108.26
54.67
Total Debt/Equity
0.02
0.02
0.04
-3.58
4.45
1.85
3.05
2.79
-100.22
93.42
Interest Cover
1.41
3.89
9.01
0.22
-0.02
1.44
0.34
0.33
0.85
0.05

News Update:


  • Panacea Biotec bags additional order from UNICEF
    24th Apr 2025, 10:22 AM

    The company has received order for supply of 40 million doses of its bivalent oral polio vaccine

    Read More
  • Panacea Biotec - Quarterly Results
    14th Feb 2025, 18:42 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.